Sandor Bioinformatics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 475.96%
(FY 2023)
- Ebitda 182.39%
(FY 2023)
- Net Worth 24.97%
(FY 2023)
- Total Assets 118.90%
(FY 2023)
About Sandor Bioinformatics
The Corporate was formerly known as Sandor Isotopes Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gunjan Sindhi and Vineeta Singh serve as directors at the Company.
- CIN/LLPIN
U74110TG2006PTC050656
- Company No.
050656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2006
- Date of AGM
06 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sandor Bioinformatics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gunjan Sindhi  | Director | 19-Jul-2006 | Current |
| Vineeta Singh | Director | 11-Jul-2022 | Current |
Financial Performance of Sandor Bioinformatics.
Sandor Bioinformatics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 475.96% increase in profit. The company's net worth Soared by an impressive increase of 24.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandor Bioinformatics?
In 2023, Sandor Bioinformatics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sandor Speciality Diagnostics Private LimitedActive 6 years 6 monthsGunjan Sindhi is a mutual person
Innovative Development Educational Technologies Private LimitedInactive For E-Filing 10 months 3 daysGunjan Sindhi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sandor Bioinformatics?
Sandor Bioinformatics has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandor Bioinformatics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandor Bioinformatics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
